User profiles for Ahmed M. Musa
 | Professor Ahmed Mudawi MusaInstitute of Endemic Diseases, University of Khartoum, Verified email at uofk.edu Cited by 7447 |
A review of partial transmit sequence for PAPR reduction in the OFDM systems
… Ahmed, ‘‘A computationally efficient selected mapping technique for reducing PAPR of …
MUSTAFA MUSA received the BS degree in computer science from the University of Baghdad, …
MUSTAFA MUSA received the BS degree in computer science from the University of Baghdad, …
[HTML][HTML] Paromomycin for the treatment of visceral leishmaniasis in Sudan: a randomized, open-label, dose-finding study
Background A recent study has shown that treatment of visceral leishmaniasis (VL) with the
standard dose of 15 mg/kg/day of paromomycin sulphate (PM) for 21 days was not …
standard dose of 15 mg/kg/day of paromomycin sulphate (PM) for 21 days was not …
[HTML][HTML] Safety and efficacy of single dose versus multiple doses of AmBisome® for treatment of visceral leishmaniasis in eastern Africa: a randomised trial
Background Anti-leishmanial drug regimens that include a single dose AmBisome® could
be suitable for eastern African patients with symptomatic visceral leishmaniasis (VL) but the …
be suitable for eastern African patients with symptomatic visceral leishmaniasis (VL) but the …
Paromomycin and miltefosine combination as an alternative to treat patients with visceral leishmaniasis in eastern Africa: A randomized, controlled, multicountry trial
…, A Nour, E Taha Ahmed Elmukashfi… - Clinical Infectious …, 2023 - academic.oup.com
Background This study aimed to determine whether paromomycin plus miltefosine (PM/MF)
is noninferior to sodium stibogluconate plus paromomycin (SSG/PM) for treatment of primary …
is noninferior to sodium stibogluconate plus paromomycin (SSG/PM) for treatment of primary …
[HTML][HTML] Safety and effectiveness of sodium stibogluconate and paromomycin combination for the treatment of visceral leishmaniasis in eastern Africa: results from a …
Introduction In 2010, WHO recommended a new first-line treatment for visceral
leishmaniasis (VL) in Eastern Africa. The new treatment, a combination of intravenous (IV) or …
leishmaniasis (VL) in Eastern Africa. The new treatment, a combination of intravenous (IV) or …
[HTML][HTML] Safety and immunogenicity of ChAd63-KH vaccine in post-kala-azar dermal leishmaniasis patients in Sudan
…, S Furini, R Wiggins, A Keding, M Carraro, AEA Musa… - Molecular therapy, 2021 - cell.com
Post-kala-azar dermal leishmaniasis (PKDL) is a chronic, stigmatizing skin condition occurring
frequently after apparent clinical cure from visceral leishmaniasis. Given an urgent need …
frequently after apparent clinical cure from visceral leishmaniasis. Given an urgent need …
[HTML][HTML] Y chromosome lineage-and village-specific genes on chromosomes 1p22 and 6q27 control visceral leishmaniasis in Sudan
Familial clustering and ethnic differences suggest that visceral leishmaniasis caused by
Leishmania donovani is under genetic control. A recent genome scan provided evidence for a …
Leishmania donovani is under genetic control. A recent genome scan provided evidence for a …
[HTML][HTML] Safety and efficacy of miltefosine alone and in combination with sodium stibogluconate and liposomal amphotericin B for the treatment of primary visceral …
Background Treatment options for Visceral Leishmaniasis (VL) in East Africa are far from
satisfactory due to cost, toxicity, prolonged treatment duration or emergence of parasite …
satisfactory due to cost, toxicity, prolonged treatment duration or emergence of parasite …
State formation and economic development in post-war Somaliland: the impact of the private sector in an unrecognised state
Unrecognised internationally, Somaliland operates as a hybrid political order where a range
of state and non-state entities provide security, representation and social services. Local …
of state and non-state entities provide security, representation and social services. Local …
Efficacy of liposomal amphotericin B (AmBisome®) in the treatment of persistent post-kala-azar dermal leishmaniasis (PKDL)
AM Musa, EAG Khalil, FA Mahgoub… - Annals of Tropical …, 2005 - Taylor & Francis
A dermatosis commonly known as post-kala-azar dermal leishmaniasis (PKDL) may develop
following the treatment of human visceral leishmaniasis (VL). In about 15% of PKDL cases …
following the treatment of human visceral leishmaniasis (VL). In about 15% of PKDL cases …